The revenue stands at ₹8,853.34 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.40 per cent from ₹8,645.90 crore. This corresponds to a year-on-year *(YoY) growth of 5.62 per cent.
Operating Profit stands at ₹1,750.35 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.48 per cent from ₹1,708.01 crore. This corresponds to a year-on-year *(YoY) decline of 0.53 per cent.
PBDT stands at ₹1,769.18 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 1.89 per cent from ₹1,803.25 crore. This corresponds to a year-on-year *(YoY) decline of 0.58 per cent.
Profit Before Tax stands at ₹1,290.61 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 3.58 per cent from ₹1,338.52 crore. This corresponds to a year-on-year *(YoY) decline of 3.33 per cent.
Net Profit stands at ₹920.84 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.21 per cent from ₹909.80 crore. This represents a 1.99 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Aurobindo Pharma | -0.30% | 2.10% | -1.74% | 17.29% | 24.30% | 25.92% |
| Dr Reddy's Labs | 0.69% | -0.89% | -1.19% | -0.67% | 0.84% | -3.15% |
| Lupin | 0.76% | 0.36% | -4.62% | -1.46% | 9.50% | 13.76% |
| Mankind Pharma | -0.79% | 0.71% | -3.72% | 8.09% | 6.94% | -0.83% |
| Laurus Labs | 1.19% | 4.22% | 17.69% | 41.74% | 44.12% | 116.91% |
| Biocon | -1.18% | -3.16% | 8.28% | 5.71% | 7.29% | 21.87% |
| Alkem Lab | -0.40% | -1.24% | -5.84% | -3.83% | -6.22% | 7.73% |
Vice Chairman & Managing Director : Kambam Nityananda Reddy
Whole-time Director : M Madan Mohan Reddy
Non Executive Director : P V Ramprasad Reddy
Independent Director : Girish Paman Vanvari
Non Executive Director : P Sarath Chandra Reddy
Independent Director : Santanu Mukherjee
Chairman & Independent Director : M R Kumar
Non Executive Director : Satakarni Makkapati
Company Sec. & Compli. Officer : B Adi Reddy
Additional Director : Punita Kumar Sinha